Veille Scientifique

La veille scientifique est un service proposé par la SNFGE. Elle se veut un recensement rapide et assez exhaustif des articles publiés dans les revues majeures (New England Journal of Medicine, Lancet, JAMA, Gastroenterology, Gut, Lancet Oncology, Journal of Clinical Oncology, Hepatology, Journal of Hepatology, Endoscopy, Gastrointestinal Endoscopy...).
 

Patrice PIENKOWSKI
 Coordinateur

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS

T. APARICIO
B. DENIS
A. LOPEZ
S. MANFREDI
Y. TOUCHEFEU

E. CHABRUN
A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
B. HANSLIK
JL. PAYEN
PE. RAUTOU
D. VALLA

H. DAMON
F. CORDET
T. HIGUERO
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
P. DELASALLE
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revue Titre Date Coup de coeur Thématique
British journal of Cancer Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours mar. 19 2 ♥ Cancers autres (hors CCR et CHC)
Digestive and Liver Disease Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma mar. 19 1 ♥ Carcinome hépatocellulaire (CHC)
Journal of clinical oncology (JCO) Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial. mar. 19 3 ♥ Cancers autres (hors CCR et CHC)
Journal of clinical oncology (JCO) Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study. mar. 19 3 ♥ Cancer colorectal (CCR)
Journal of clinical oncology (JCO) Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. mar. 19 4 ♥ Cancers autres (hors CCR et CHC)
Journal of clinical oncology (JCO) Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. fév. 19 3 ♥ Carcinome hépatocellulaire (CHC)
Gut Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose. fév. 19 3 ♥ Foie
Gastroenterology Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features. fév. 19 4 ♥ Pancréas/Voies biliaires
The Lancet Oncology Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial. fév. 19 5 ♥ Carcinome hépatocellulaire (CHC)
International Journal of Colorectal Disease Infectious proctitis: a necessary differential diagnosis in ulcerative colitis. fév. 19 3 ♥ Colo-proctologie
Gastroenterology RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis. fév. 19 4 ♥ Colo-proctologie
Hepatology Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2). fév. 19 3 ♥ Foie (hors cancers)
Hepatology Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis. fév. 19 4 ♥ Foie
Hepatology Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease. fév. 19 4 ♥ Foie
Hepatology The NACSTOP Trial: A Multicenter, Cluster-Controlled Trial of Early Cessation of Acetylcysteine in Acetaminophen Overdose. fév. 19 4 ♥ Foie
Hepatology Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r. fév. 19 4 ♥ Foie
Hepatology Liver Complications Following Treatment of Hematologic Malignancy With Anti-CD22-Calicheamicin (Inotuzumab Ozogamicin). fév. 19 3 ♥ Foie
Gastroenterology Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis. fév. 19 4 ♥ Foie
The Lancet Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. fév. 19 4 ♥ Foie
Clinical Gastroenterology and Hepatology Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis. Jan. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology No Association Between Consumption of Sweetened Beverages and Risk of Later-Onset Crohn's Disease or Ulcerative Colitis. Jan. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases Jan. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis Jan. 19 3 ♥ MICI
Gut Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014 Jan. 19 4 ♥ MICI
Journal of the American Medical Association (JAMA) Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial Jan. 19 5 ♥ MICI

Pages